OpenAccess ® AetnaSelect SM -ASC PROVIDEDBYAETNALIFEINSURANCECOMPANY PREFERREDCARE Covered100% $15officevisitcopay 7examsinthefirst12monthsoflife,2examsinthe13th-24thmonthsoflife;1examper12monthsthereaftertoage18. 1examper24monthsformembersage18toage65;1examper12monthsforadultsage65andolder. ...
Aetna considers radiofrequency ablation (open, laparoscopic (e.g., the Acessa System), or transcervical (e.g., the Sonata System)) or transcatheter uterine artery embolization (UAE, e.g., by means of tris-acryl gelatin microspheres (Embospheres Microspheres)) medically necessary as an alternati...
A literature search was carried out by an information specialist on key resources including Medline, Embase, the Cochrane Library, the University of York Centre for Reviews and Dissemination (CRD) databases, the websites of Canadian and major international health technology agencies, as well as a f...
InTENsity Select Combo electrical stimulator for all indications; or TENS with ICS; or TENS with NMES (e.g., Empi Phoenix, QB1 System); or TENS with ultrasound device; or Transcranial direct current stimulation and breathing-controlled electrical stimulation for the treatment of neuropathic pain af...
Patients, providers, and researchers were blinded to treatment assignment. A total of 50 women aged 18 to 59 years with CFS and severe fatigue leading to functional impairment were included in this study. Participants were randomly assigned to daily subcutaneous anakinra, 100 mg (n = 25), or ...
The use of LITT may be a reasonable option in bundled episodes of care for brain cancer and may fit into the Bundled Payment for Care Improvement (BPCI) program being evaluated by Medicare and providers. The authors stated that drawbacks of this analysis included its retrospective nature and ...
Specific objectives were to select a salivary biomarker panel suitable for early detection of OSCC and OPMD and to evaluate relationships between salivary biomarkers and risk factors. They carried out electronic literature search in academic databases (Scopus, Medline, Embase and Web of Science) ...
Providers should be aware of this rare but potentially fatal complication and the importance of close clinical monitoring and serial abdominal examinations following AngioVac procedures. Qintar et al (2022) stated that the AngioVac system was approved for right-sided transcatheter vacuum-assisted mass ...
Care providers and investigators were masked to the computer-generated treatment assignment. The primary outcome was survival without development of BPD at post-menstrual age 36 weeks. Analysis was by intention-to- treat. A total of 399 infants were assigned to INO, and 401 to placebo; 395 and...
The lack of a significant survival benefit with FETO in fetuses with moderate pulmonary hypoplasia should prompt providers to encourage participation in additional randomized trials of FETO efficacy and outcomes and to avoid offering FETO outside such trials. The editorialist concluded that the current...